Literature DB >> 16508299

CADASIL: a critical look at a Notch disease.

Angeliki Louvi1, Joseph F Arboleda-Velasquez, Spyros Artavanis-Tsakonas.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a catastrophic late-onset syndrome which manifests itself mainly as a central nervous system degenerative disorder. CADASIL has been associated with mutations in the Notch 3 receptor which appear to cause, mainly, vascular abnormalities. Although more than a decade has passed since Notch 3 mutations were linked with this disease, we still do not have a good grasp on the molecular mechanisms underlying the CADASIL-associated Notch 3 receptor malfunction, nor do we understand many aspects of the CADASIL pathobiology. In this review, we discuss the CADASIL-related literature and attempt to evaluate the various experimental systems and approaches used to address what seems to be a paradigm for studying the pathobiology and genetics of vascular cognitive impairment. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508299     DOI: 10.1159/000090748

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  26 in total

Review 1.  Non-canonical activation of Notch signaling/target genes in vertebrates.

Authors:  Rajendran Sanalkumar; Sivadasan Bindu Dhanesh; Jackson James
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  O-glucose trisaccharide is present at high but variable stoichiometry at multiple sites on mouse Notch1.

Authors:  Nadia A Rana; Aleksandra Nita-Lazar; Hideyuki Takeuchi; Shinako Kakuda; Kelvin B Luther; Robert S Haltiwanger
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 3.  The canonical Notch signaling pathway: unfolding the activation mechanism.

Authors:  Raphael Kopan; Maria Xenia G Ilagan
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 4.  Dll4-Notch signaling in regulation of tumor angiogenesis.

Authors:  Zhaoguo Liu; Fangtian Fan; Aiyun Wang; Shizhong Zheng; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-10       Impact factor: 4.553

Review 5.  ADAM proteases: ligand processing and modulation of the Notch pathway.

Authors:  A Zolkiewska
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

6.  Linking Notch signaling to ischemic stroke.

Authors:  Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

7.  Where will the next generation of stroke treatments come from?

Authors:  D W Howells; G A Donnan
Journal:  PLoS Med       Date:  2010-03-02       Impact factor: 11.069

Review 8.  Notch: from neural development to neurological disorders.

Authors:  Justin D Lathia; Mark P Mattson; Aiwu Cheng
Journal:  J Neurochem       Date:  2008-12       Impact factor: 5.372

Review 9.  A Notch updated.

Authors:  An-Chi Tien; Akhila Rajan; Hugo J Bellen
Journal:  J Cell Biol       Date:  2009-03-02       Impact factor: 10.539

10.  Notch signaling in cardiovascular disease and calcification.

Authors:  Gabriel Rusanescu; Ralph Weissleder; Elena Aikawa
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.